Revising the Guidance Document for Biosimilar Agents
Health Canada, the national department responsible for regulating food, health and consumer products to keep Canadians safe, published the Guidance Document: Information and Submission Requirements for Biosimilar Biologic Drugs on 14 November 2016 to update its framework for the market authorization...
Saved in:
Main Author: | Steven Williams (Author) |
---|---|
Format: | Book |
Published: |
McMaster University Library Press,
2017-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Revising the Guidance Document for Biosimilar Agents
by: Steven Williams
Published: (2017) -
Effectiveness guidance document (EGD) for acupuncture research - a consensus document for conducting trials
by: Witt Claudia M, et al.
Published: (2012) -
Review of sun exposure guidance documents in Australia and New Zealand
by: Christina Verma, et al.
Published: (2022) -
Biosimilar medicines and cost-effectiveness
by: Steven Simoens
Published: (2011) -
Documenting of extravasation of cytotoxic agents
by: Savić Maja, et al.
Published: (2020)